Maryland is one of 38 US states, along with three territories and the District of Columbia, that have legalized cannabis for ...
Maryland is one of 38 US states, along with three territories and the District of Columbia, that have legalized cannabis for ...
Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology ...
The University of Maryland Institute for Health Computing (UM-IHC) held its first-ever Continuing Medical Education course on ...
Johnny Holliday and Rich Chvotkin, with 99 seasons and more than 3,000 games between them, are still on the call for the ...
Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and ...
News Medical on MSN
Early-stage clinical trial demonstrates promise of intranasal influenza vaccine in generating broad immunity
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) report ...
Most patients with sickle cell disease who go to the ED for vaso-occlusive crises do not get triaged according to guideline ...
2dOpinion
Make Medical School Three Years
With the government abrogating its role in supporting medical students, the onus falls on medical schools to rethink how ...
Oral and Facial Surgery Associates, LLC is pleased to welcome Dr. Marie-Chantale Farhat to its team of oral and ...
Novel Aldosterone Synthase Inhibitor Lorundrostat Shows Promise for Uncontrolled Hypertension in CKD
A new aldosterone synthase inhibitor added to SGLT2 inhibitors reduces uncontrolled blood pressure in patients with chronic kidney disease, according to the results of a phase 2 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback